Who owns the AVERITAS trademark?

The AVERITAS trademark is owned by Averitas Pharma, Inc..

What is the serial number for AVERITAS?

The USPTO serial number for AVERITAS is 97978643.

What is the registration number for AVERITAS?

AVERITAS is registered under USPTO registration number 7531917.

AVE

USPTO Trademark Record

REGISTERED

AVERITAS

Q: What class is the AVERITAS trademark registered in?

The AVERITAS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

SN 97978643·Reg 7531917·Filed Feb 09, 2023

Owner Averitas Pharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

AVERITAS (Serial No. 97978643), Registration No. 7531917, is a registered US trademark filed on Feb 09, 2023 by Averitas Pharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

early section 8: October 08, 2030

Mark Intelligence

AVERITAS (Reg. #7531917) is a registered US trademark that has been protecting its owner, Averitas Pharma, Inc., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 09, 2023

SERIAL

97978643

REG#

7531917

REGISTERED

Oct 08, 2024

Owner

Applicant

Averitas Pharma, Inc.

Entity

Corporation

State

Address

360 Mount Kemble Ave., Morristown, NJ, 07960

Country

Attorney

NamePaul C. Llewellyn

Law firm

Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP

Docket

1101804.0002

Address

601 MASSACHUSETTS AVE., NW, IP DOCKETING, WASHINGTON, DC 20001, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 09, 2023

Serial Number97978643

Registration No.7531917

Registration DateOct 08, 2024

Status DateOct 08, 2024

Published for OppositionDec 12, 2023

Mark TypeDesign with words

Attorney Docket1101804.0002

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 16, 2023

First use in commerce: Oct 16, 2023

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Oct 16, 2023

First use in commerce: Oct 16, 2023

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

28 events

REGISTERED-PRINCIPAL REGISTER

Oct 08, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 08, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 29, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 29, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Aug 29, 2024

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

DIVISIONAL PROCESSING COMPLETE

Aug 12, 2024

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Aug 12, 2024

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 08, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Aug 06, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 GRANTED

Aug 06, 2024

SOU EXTENSION 1 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 06, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 02, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SOU EXTENSION 1 FILED

Aug 02, 2024

SOU EXTENSION 1 FILED

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

Jul 08, 2024

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 04, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

May 02, 2024

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

May 02, 2024

TEAS STATEMENT OF USE RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

May 02, 2024

TEAS REQUEST TO DIVIDE RECEIVED

DIVISIONAL REQUEST RECEIVED

May 02, 2024

DIVISIONAL REQUEST RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 06, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 12, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 12, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 22, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 09, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 08, 2023

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 01, 2023

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 28, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 13, 2023

NEW APPLICATION ENTERED

AVERITAS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Averitas Pharma, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Paul C. Llewellyn

Resources

Company